Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.22.4
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Accounts receivables and contract assets, allowance for credit losses $ 28 $ 28
Long-term debt fair value $ 237 $ 268
Series A    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 200,000,000 200,000,000
Common stock shares issued 72,641,163 72,447,462
Common stock, shares outstanding 72,641,163 72,447,462
Series B    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 7,500,000 7,500,000
Common stock shares issued 3,370,368 3,216,047
Common stock, shares outstanding 3,370,368 3,216,047
Series C    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 200,000,000 200,000,000
Common stock shares issued 0 0